Filing Details

Accession Number:
0000899243-20-008616
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-03-17 16:38:45
Reporting Period:
2020-03-16
Accepted Time:
2020-03-17 16:38:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1341235 Aldeyra Therapeutics Inc. ALDX Biological Products, (No Disgnostic Substances) (2836) MA
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1021015 Richard Douglas C/O Aldeyra Therapeutics, Inc.
131 Hartwell Avenue, Suite 320
Lexington MA 02421
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-03-16 40,000 $2.75 125,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct